Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Treatment of Lenalidomide Expo...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens

Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens

Bibliographic Details
Main Authors: Cirino Botta, Enrica Antonia Martino, Concetta Conticello, Francesco Mendicino, Ernesto Vigna, Alessandra Romano, Giuseppe Antonio Palumbo, Claudio Cerchione, Giovanni Martinelli, Fortunato Morabito, Francesco Di Raimondo, Massimo Gentile
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
myeloma
network meta analysis
daratumumab
lenalidomide
bortezomib
carfilzomib
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.643490/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.643490/full

Similar Items

  • Long-term continuous treatment as a new strategy for relapsed or refractory multiple myeloma
    by: S. V. Semochkin
    Published: (2020-07-01)
  • Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
    by: Celine Berthon, et al.
    Published: (2020-01-01)
  • Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
    by: T. A. Мitinа, et al.
    Published: (2015-12-01)
  • Carfilzomib, lenalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience
    by: Vera A. Zherebtsova, et al.
    Published: (2021-07-01)
  • Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
    by: K. A. Belousov, et al.
    Published: (2019-04-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...